Mondon F, Doualla-Bell Kotto Maka F, Sabry S, Ferré F
INSERM U.361, Université René Descartes, Paris, France.
Eur J Endocrinol. 1995 Nov;133(5):606-12. doi: 10.1530/eje.0.1330606.
In the present study, we examined the relationship between endothelin receptors and phosphoinositide breakdown in muscle explants of placental stem villi vessels. All peptides examined, i.e. endothelin-1 (ET-1), ET-3, sarafotoxin 6b (S6b) and S6c, were able to induce phosphoinositide hydrolysis in a dose-dependent manner: ET-1 was more potent than S6b and ET-3, with corresponding EC50 values of 44 +/- 16 pmol/l, 18 +/- 13 nmol/l and 33 +/- 24 nmol/l, respectively. Sarafotoxin induced only moderate stimulation of inositol phosphate accumulation. Both ET-1- and S6b-induced accumulation of inositol phosphate was almost totally (90%) inhibited by 100 mumol/l BQ 123, while the S6c response was not affected by the ETA receptor antagonist. In contrast, the ETB receptor antagonist IRL 1038 inhibited S6c-induced inositol phosphate accumulation by more than 80%, whereas inhibition was only about 30% for ET-1 and S6b stimulations. This indicates that both ETA and ETB receptors were coupled to the phospholipase C transducing system in the muscular layer of placental stem villi vessels, and there is evidence that the phosphoinositide hydrolysis response is obtained predominantly via ETA receptor activation.
在本研究中,我们检测了胎盘绒毛干血管肌肉外植体中内皮素受体与磷酸肌醇分解之间的关系。所检测的所有肽类,即内皮素-1(ET-1)、ET-3、沙雷肽素6b(S6b)和S6c,均能以剂量依赖方式诱导磷酸肌醇水解:ET-1比S6b和ET-3更有效,相应的半数有效浓度(EC50)值分别为44±16 pmol/L、18±13 nmol/L和33±24 nmol/L。沙雷肽素仅适度刺激肌醇磷酸积累。100 μmol/L的BQ 123几乎完全(90%)抑制了ET-1和S6b诱导的肌醇磷酸积累,而S6c反应不受ETA受体拮抗剂的影响。相反,ETB受体拮抗剂IRL 1038抑制S6c诱导的肌醇磷酸积累超过80%,而对ET-1和S6b刺激的抑制率仅约为30%。这表明ETA和ETB受体均与胎盘绒毛干血管肌层中的磷脂酶C转导系统偶联,并且有证据表明磷酸肌醇水解反应主要通过ETA受体激活获得。